ECDC launches e-learning course and operational tool for development of rapid risk assessments
ECDC launches a new e-learning course on rapid risk assessments (RRA) as well as an operational tool that describes the RRA methodology used by the Centre. The course and the tool support public health experts responsible for developing RRAs at European, national or sub-national level.
ECDC Director speaks at ICREID, 2nd International Conference on (re-)emerging infectious diseases
The International Conference on (re-)emerging infectious diseases (ICREID) is taking place in Addis Ababa, Ethiopia from 13 to 15 March 2019.
Citizen’s dialogue with Commissioner Andriukaitis and ECDC Director Andrea Ammon
ECDC Director Andrea Ammon and Vytenis Andriukaitis, EU Commissioner for Health and Food Safety, will engage in a public debate with citizens in Sweden to highlight how prevention of infectious diseases, vaccination programmes, actions against rare diseases and promotion of good health through healthy life styles are all aspects where EU policies can and do play an important role.
WHO recommendations for influenza virus vaccine composition for the 2019–2020 northern hemisphere season
On 18–20 February 2019, the World Health Organization (WHO) agreed on the recommended composition of the quadrivalent influenza vaccine for the northern hemisphere 2019–2020 influenza season: an A/Brisbane/02/2018 (H1N1)pdm09-like virus, an A(H3N2) virus component to be announced on 21 March 2019, a B/Colorado/06/2017-like virus (B/Victoria/2/87 lineage) and a B/Phuket/3073/2013-like virus (B/Yamagata/16/88 lineage).
Gonorrhoea: drug resistance compromises recommended treatment in Europe
Gonorrhoea is the second most commonly notified sexually transmitted infection across the EU/EEA countries with almost 500 000 reported cases between 2007 and 2016. The infection is treatable but Neisseria gonorrhoeae keep showing high levels of azithromycin resistance according to latest results of the European Gonococcal Antimicrobial Surveillance Programme.
Zoonoses: antimicrobial resistance shows no signs of slowing down
Data released today by the European Centre for Disease Prevention and Control (ECDC) and European Food Safety Authority (EFSA) reveal that antimicrobials used to treat diseases that can be transmitted between animals and humans, such as campylobacteriosis and salmonellosis, are becoming less effective.
Heads of Agencies network meets in Brussels under ECDC chairmanship
On 12-13 February, the Heads of EU Agencies meet in Brussels in their regular network meeting to discuss matters of common interest to all agencies.
EU/EEA NITAG collaboration for the sharing and synthesis of scientific evidence on EU authorised vaccines and their use in immunisation practices
The 1st Meeting of the EU/EEA NITAG collaboration for the sharing and synthesis of scientific evidence on EU authorised vaccines and their use in immunisation practices will be held at the ECDC premises in Stockholm on 12-14 of February, 2019.
ECDC’s HEPSA preparedness self-assessment tool is now available in all EU/EEA languages
The HEPSA (Health Emergency Preparedness Self-Assessment) tool that ECDC launched in 2018 in English is now available in all EU/EEA languages. This tool aims at supporting countries in improving their level of public health emergency preparedness.